发明授权
- 专利标题: Compositions for intranasal administration
- 专利标题(中): 鼻内管理组成
-
申请号: US11665148申请日: 2005-10-10
-
公开(公告)号: US08202550B2公开(公告)日: 2012-06-19
- 发明人: Michael James , Peter Josling
- 申请人: Michael James , Peter Josling
- 申请人地址: GB Ramsey
- 专利权人: Nasaleze PPM Limited
- 当前专利权人: Nasaleze PPM Limited
- 当前专利权人地址: GB Ramsey
- 代理机构: Head, Johnson & Kachigian, P.C.
- 优先权: GB0422582.7 20041011; GB0502792.5 20050210; JP2005-209097 20050719; GB0519213.3 20050921
- 国际申请: PCT/GB2005/050179 WO 20051010
- 国际公布: WO2006/040596 WO 20060420
- 主分类号: A61K36/00
- IPC分类号: A61K36/00 ; A61K36/53 ; A61K36/84 ; A61K36/16 ; A61K36/8962 ; A61K36/481 ; A61K31/733 ; A61K36/31 ; A61K36/254 ; A61K36/752 ; A61K36/61 ; A61K35/534
摘要:
Pharmaceutical compositions are for administration to the nasal tract. In particular, dry powder compositions are cellulose, and in particular hydroxypropylmethylcellulose (HPMC), and one or more therapeutic agents. It has been shown that administration of HPMC to the nasal cavity is capable of enhancing natural mucus. These powders, and the gel that forms when they are administered to the nasal tract, have now surprisingly been found to be a very effective way of intranasally administering therapeutic agents, and in particular, herbal or homeopathic agents.
公开/授权文献
- US20100297269A1 Compositions for intranasal administration 公开/授权日:2010-11-25
信息查询